Search Result "AMG-386"


Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3 Issue: 4 Year: 2014 Page: 193-202
Author(s): Al Wadi Khalid,Ghatage Prafull

Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2702-2712
Author(s): Marco Petrillo,Maddalena Borriello,Gilda Fuoco,Francesco Legge,Vito Iannone,Gabriella Ferrandina

Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1005-1024
Author(s): K. Podar, K. C. Anderson

Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 3 Year: 2013 Page: 313-325
Author(s): Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni, Stefano Cascinu

Systematic Review Article

Current Status of Pharmacokinetic Research of Clinical Trial Records inthe Female Population in India: A Systematic Review

Journal: Current Women`s Health Reviews
Volume: 20 Issue: 2 Year: 2024 Page: 134-143
Author(s):

Drug Discovery in Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 3 Year: 2010 Page: 251-260
Author(s): Dana M. Chase, Nidhee Mathur, Krishnansu S. Tewari

Angiopoietin-2 Axis Inhibitors: Current Status and Future Considerations for Cancer Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 2 Issue: 1 Year: 2013 Page: 2-12
Author(s): Nikolett Molnar, Dietmar W. Siemann

Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

Journal: Current Angiogenesis (Discontinued)
Volume: 3 Issue: 2 Year: 2014 Page: 73-79
Author(s): Nabil Ismaili

Research Article

An in silico Immunogenicity Analysis for PbHRH: An Antiangiogenic Peptibody by fusing HRH Peptide and Human IgG1 Fc Fragment

Journal: Current Bioinformatics
Volume: 15 Issue: 6 Year: 2020 Page: 556-561
Author(s): Lin Ning,Jiang Huang,Bifang He,Juanjuan Kang

Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3932-3957
Author(s): Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli, Angel Luis G. Ponce

Previous   Next

Go To   Results 1 - 1 of 85

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy